OBJECT/VE: To determine the rates of resolution of symptoms and return to premorbid health status and assess the association of these outcomes with health care utilization in patients with community-acquired pneumonia.
p revious studies of outcomes in patients with conmmnity-acquired pneumonia have focused primarily on early mortality following pneumonia in comparing out comes across different patient groups, microbiologic etiologies, or types of care. 14 However, there is growing appreciation that for most patients with pneumonia, especially those at very low risk of dying, the time course of symptomatic and functional recovery is also of great importance.S Classically, the rate of resolution of pneumonia has been defined in terms of the resolution of radiographic ab normalities associated with the illness, s However, recovery as defined by chest radiography is an imperfect stan dard and has not been routinely correlated with clinically memlingful variation in outcomes. 7 Alternatively, recovery can be measured based on patient reported health status, but the published literature lacks any instruments to spe cifically measure recovery from pneumonia. Although generic instruments, such as the Medical Outcomes Study 36 Item Short Form Health Survey (SF 36), are available, they are theoretically less responsive to variations in disease outcomes than specific instruments, in part because specific instruments include only those items that are rel evant to the disease under study, s
As part of a cohort study of outcomes in patients with community acquired pneumonia, we developed an instru ment to measure recovery from pneumonia based on the resolution specific symptoms common to patients with pneumonia. The specific aims of the current study are as follows: (1) to compare the time course of recovery as measured by two outcomes measures, the generic SF36 and our pneumonia symptom questionnaire, in patients recovering from pneumonia; and (2) to validate the pneumonia symptom questionnaire as a predictor of health care utilization.
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METHODS
The data for this investigation were obtained as part of the Pneumonia Patient Outcomes Research Team (PORT) multicenter, prospective cohort study of medical outcomes in ambulatory and hospitalized patients with community-acquired pneumonia,
Study Sites
The study was performed at five medical institutions in three geographic locations: the University of Pittsburgh Medical Center and St. Francis Medical Center, in Pitts burgh, Pennsylvmlia; the Massachusetts General and the Harvard Community Health Plan Kenmore Center, in Boston, Massachusetts; and the Victoria General Hospi tal, in Halifax, Nova Scotia, Canada,
Study Population
The population for this study, known as the detailed study group, was drawn from the larger cohort of patients assembled for the Pneumonia PORT cohort study. Poten tial study subjects were identified by screening patients presenting to emergency departments, medical walk-in clinics, and practitioner offices affiliated with the partici pating sites, Cohort study inclusion criteria were (1) age of at least 18 years; (2) acute onset of at least 1 of 18 clinical symptoms suggestive of acute illness; (3) chest radio graphic evidence of acute pneumonia within 24 hours of presentation; and (4) informed consent by the patient or patient proxy. Patients were ineligible for the cohort study if they were discharged from the hospital within the 10 days preceding presentation, were known to be HIV posi tire, or were previously enrolled in the cohort study.
The detailed study cohort was assembled as a consecutive sample of patients with low severity of illness en rolled at the study sites from October 1991 to June 1993. Severity of illness was based on a multivariable model that categorized patients as at low, moderate, or high risk of 60 day mortality based on information available at the time of study enrollment (see below). Study patients who met eligibility criteria were asked to participate in a more detailed study of medical outcomes, with an increased number of questionnaires and duration of follow-up, Only patients who completed questionnaires at all four time points were included in this study. In addition, a small number of patients who required proxies, e.g., relatives or caregivers, to complete the questionnaires were excluded from the study because of the biases documented in other studies comparing caregiver reports of patient health with sel~report information. 9 11
Overall, 1,485 (65%) of the 2,287 patients enrolled in the Pneumonia PORT cohort study were categorized as at low risk of short-tern1 mortality based on the pneumonia severity of illness index, calculated at the time of study enrollment. Of the 939 low-risk patients who were enrolled in the cohort study during the recruitment period for the detailed study group, 707 (75%) participated in the detailed study. Reasons for nonparticipation in the detailed assessment included patient and physician requests (25%), language barriers (13%), and cognitive or psychiatric impairment (12%). Of the patients enrolled in the detailed study, 576 (81%) provided selSreported an swers to the follow up questionnaires at all four time points mid were included in this substudy.
Baseline Data Collection
Baseline data were collected on all patients within 6 days of diagnosis of pneumonia through chart abstraction and patient interview, Data included demographic characteristics, comorbid illnesses, physical examination findings, and laboratory findings. On the basis of 20 variables available at the time of diagnosis, patient severity of illness was categorized as low, moderate, or high. The severity levels were based on a previously validated pneu monia severity of illness index derived from a logistic regression model of short term mortality in patients with pneumonia (predicted probability of death <4% for low risk). 1
Outcomes Assessment
All patients enrolled in the detailed study provided responses to an initial questionnaire (day 0) and three fol low-up questionnaires (days 7, 30, and 90 from the time of radiographic diagnosis), At the time of the initial questionnaire, patients were also asked to evaluate their symptoms and health status 1 month before the onset of their illness with pneumonia (prepneumonia), All questionnaires were administered either by interview (either in person or by telephone) with one or two trained research assistants per site, or by written completion of a mailed version of the questionnaire. The distribution of these modes of administration ranged from 99.5% of patients providing responses by interview for the initial question nalre to 60% of patients providing responses by interview and 380/0 by written completion of mailed questionnaires for the day 90 follow up questionnaire.
The items in the symptom questionnaire were se lected by a panel of investigators (MJF, TJM, CMC, WNK, and DES) based on an analysis of symptoms at presenta tion in patients enrolled in two previous cohort studies of community-acquired pneumonia, s,ls The questionnaire included the most prevalent respiratory symptoms identified in those earlier studies. Questions on fatigue were added because fatigue was hypothesized to be important to patients during the longitudinal follow-up, The scaling of the response categories for the severity of respiratory symptoms was primarily based on modifications of an instrument used to quantitate symptoms in patients with chronic lung disease, 14 while the questions on fatigue were adapted from a previously validated questionnaire JGIM Volume t2, Jrt~y 1997 425 on chronic fatigue, is Ultimately, the instrument included questions on the presence and severity of five symptoms (cough, dyspnea, sputum production, pleuritic chest pain, mid fatigue), Severity of cough, pleuritic chest pain, and fatigue were based on a 5 point scale (1 = mild to 5 = severe); severity of dyspnea on a 4-point scale (1 with significant physical activity to 4 at rest); and severity of sputum production on a 3 point scale (1 = less than 2 tablespoons to 3 1/~ cup or more).
The SF-36 was administered at the initial and followup interviews using the "1 week" recall period rather than the standard "4-week" recall period, is The primary measure of health resource utilization was based on patient selgreporting of outpatient physician visits at each follow up time point, Patients provided information on the number of outpatient physiciml visits as well as a brief reason for each visit that occurred in the interval between subse quent follow-up interviews. One of the study investigators (JPM), blinded to the remaining outcomes data, coded the outpatient visits as pneumonia related or pneumonia unrelated according to a set of criteria developed to interpret the reasons provided by patients for visits. Reasons for coding visits as pneumonia unrelated included periodic or routine examinations for health maintenance (e,g., blood pressure follow up), urgent visits for alternative diagnoses (e.g., bladder infection, headache), and follow up visits after 30 days without a stated reason, The remaining visits were coded as pneumonimrelated oflice visits. In a random sam piing of 30 patients, the agreement rate for coding the visits between the study investigator and an independent investigator was 970/o (K 0,91).
Analytical Methods
The generalizability of the study sample was assessed by comparing baseline demographic mid clinical variables between the detailed study group and the remaining low severity of illness patients, using Fisher's Exact Test (for categorical variables) 17 and the Mantel-Haenszel X: test for trend (for ordinal variables), 18 For the analysis of symptom resolution over time, both the proportion of all patients reporting each symptom at each time point and the proportion of all patients reporting moderate to severe symptoms were calculated. For each patient, a summary symptom score was calculated at each time point as follows: the severity scale for each of the five symptoms was transformed into a 6 point scale from 0 (no symptom) to 5 (severe symptom) so that each symptom would contribute equally to the summary severity score. The sum of the five severity scales (range 0-25) was then trmlsformed (through direct multiplication) into a 0 to 100 scale for ease of comparison with the SF36 scales. Mean values for the pneumonia symptom score, along with the standard deviations, were calculated at each time point. The internal reliability of the symptom score was calculated at each time point based on Cron bach's a statistic.19
The distribution of the symptom scores over time was presented based on five levels of the symptom score (020, 21-40, 41-60, 61-80, and 81-100). These levels were chosen because a 20-point change in the scale may represent a clinically meaningful change in symptom reporting. For example, the chmlge resulting from either a single symptom improving from its most severe level to its absence or all symptoms improving by a single severity point would result in a 20-point change in the scale, For the analysis of SF 36 scale resolution over time, mean scores were cal culated for each of the eight scales. Patients with missing responses were excluded, and the proportion of missing data is reported in each table or figure. However, patients were eliminated from the calculation of scores of the SF36 only if more than half of the items for each multi-item scale were missing. 16 A comparison of the sensitivity of different scales in measuring chmlge in patients recovering from pneumonia was based on calculations of the effect size for each scale for each follow up time interval. Effect size was estimated as the mean change in the score for each scale between any two time periods divided by the standard deviation of the score at the initial time period. S~ As there is no "gold standard" for recovery from pneumonia, the pneumonia symptom score was validated against the criterion of future pneumonia related ambula tory medical care. We hypothesized that patients with higher symptom scores would be more likely to subsequently seek medical attention for their illness. This hy pothesis was tested on symptom scores based on the day 0, day 7, and day 30 assessments, For the univariate analyses, the proportions of patients who reported a pneumonia-related mnbulatory care visit were compared for each level of symptom scores recorded at the previous assessments. For example, symptom scores based on the day 7 assessment were used to predict the probability that a pneumonia related ambulatory care visit was re ported at the subsequent day 30 or day 90 follow up eval uations, Statistical significmlce was based on the MantelHaenszel X ~ test for trend. Logistic regression analysis was performed to adjust for prespecified sociodemographic and clinical predictors on the impact of the symptom score on subsequent reporting of pneumonia related ambulatory care visits. The level of the symptom score was added as a categorical predictor to a logistic regression model that included terms for age, site of care, the presence of pulmonary or cardiovas cular comorbidities, mid the severity of illness index. Table 1 compares the baseline demographic and clinical characteristics of the 576 patients in the detailed population assembled for this study and the remaining 909 low-risk cohort study patients. The detailed study population was younger (78% < 60 years vs 70%, p ,001), and a greater proportion were female, employed, or highly educated. In addition, although distribution of co morbidities did not vary significantly between the two groups, the detailed study group was more likely to be treated in the outpatient setting and had a slightly higher 30-day survival rate (100% vs 99%, p ,046).
RESULTS
Patient Characteristics
Patient Reporting of Symptom Resolution
Fatigue (93%) and cough (90%) were the most commonly reported symptoms at the time of study enrollment (day 0, Table 2A ). All symptoms showed a stepwise decline in reported prevalence with each subsequent follow-up, but there was still substantial symptom reporting at the day 90 follow up. Fatigue was reported by 51% of patients at day 90, which was still nearly twice the frequency reported as prepneumonia (29%). Similarly, at the day 90 follow up, cough (32%) and sputum (27%) were reported more than twice as often compared with their respective prepneumonia levels.
The majority of patients rated their symptoms of fa tigue (79%) and cough (80%) as moderate to severe (i.e., at the two highest levels of the severity scale) at the time of diagnosis, while only a minority of patients rated their symptoms as moderate to severe at the day 30 or day 90 follow ups (Table 2B) . Still, 20o/0 of patients reported mod erate to severe fatigue and 13% reported moderate to se vere cough at day 90, twice the levels reported as prepneumonia.
The pneumonia symptom score was calculated based on the sum of all five symptom severity scales. The internal reliability of the score, as measured with Cronbach's ~, ranged over the follow-up time points from 0,5 for the prepneumonia and day 0 scores to 0,7 for the day 30 and day 90 scores. As shown in Figure 1 , the vast majority of patients recalled having few to no symptoms at a time before the onset of pneumonia, corresponding to the lowest level of the symptom score (score = (~20). At the time of diagnosis, there was a wide distribution of symptom scores, At each successive follow-up assessment, a greater 
Patient Reporting of Health Status over 1]me
The calculated scores for the four physical and four m e n t a l health c o n c e p t s derived from the S F 3 6 are pre sented in Table 3 . For these m e a s u r e s , a higher score implies better health. All scales d e m o n s t r a t e d m a x i m u m de cline from the p r e p n e u m o n i a levels at day 0. The greatest decline was noted for the metal score for physical role functioning, w h i c h declined from 81.7 (prepneumonia) to 10.4 (day 0). The least decline w a s noted for the m e a n score for m e n t a l health, which declined from 80.3 (prep n e u m o n i a ) to 65.1 (day 0). All scales improved in a step wise fashion over the three follow-up time points, including from day 30 to day 90.
Comparison of the Sensitivity of Outcomes Scales
We calculated the a m o u n t of change b e t w e e n e a c h successive follow-up period detected by each o u t c o m e scale and expressed these as b o t h a raw change score a n d a standardized effect size (ES), defined as the m e a n change score divided by the s t a n d a r d deviation of the score at the initial time point (Table 4) . For reference, a n ES of 0,2 is considered small, 0.5 is considered moderate, a n d 0.8 or greater is considered large. ~~ Of note, the effect sizes for the p n e u m o n i a s y m p t o m score are negative, re flecting i m p r o v e m e n t with a decline in the scale, while the effect sizes for the SF-36 scales are positive, reflecting imp r o v e m e n t with a n increase in the scales. All scales s h o w e d a statistically significant a m o u n t of change over e a c h follow-up time period (p < .05). W h e n we a d j u s t e d for multiple comparisons, a n d required a p value < .001 for significance, all scale c h a n g e s r e m a i n e d significant except for the chmlge for days 7 to 30 in the SF-36 scale for general h e a l t h perception and the c h a n g e s for days 30 to 90 in the SF-36 scales for bodily pain, general health perception, a n d m e n t a l health, Over the first 7 days of recovery, the p n e u m o n i a s y m p t o m score showed the greatest a m o u n t of change (ES 1.0), followed by the SF-36 scales for bodily pain (ES = 0.9) and vitality (ES = 0.7). 
Relation of Pneumonia Symptom Score to Pneumonia-Related Ambulatory Care Visits
We assessed the relation of persistent symptoms with increased use of health resources as a means of validating the pneumonia symptom score. At the day 30 follow-up, 337 patients (59%) reported at least one ambulatory care visit since the day 7 assessment; of these, 284 (84%) re ported at least one pneumonia-related ambulatory visit.
At the day 90 follow-up, 294 patients (55%) reported at least one ambulatory visit since the day 30 assessment; of these, 80 (27%) reported at least one pneumonia-related ambulatory visit, Table 5 
DISCUSSION
The majority of patients with pneumonia are treated in the outpatient setting mid have a correspondingly low risk of short-tern1 mortality or serious morbidity related to their illness. Increasingly, there is pressure to identify similar low-risk patients in the hospital setting and discharge them to home at the time of diagnosis or after a shortened length of stay. Whether these strategies will ac tually improve the quality of care for patients with pneumonia is unknown. However, we cannot study these strategies until we develop and test instruments that have sufficient accuracy and sensitivity to measure rates of recovery in these patients.
This study represents the first attempt to develop and validate an instrument to specifically measure symptomatic recovery in patients with pneumonia. This pneumo nia symptom questionnaire can be completed by patients themselves or administered through an interview. Our findings suggest that this new measure is responsive to patients' recovery from pneumonia over a prolonged time interval. In addition, the score was shown to have validity insofar as it predicted future pneumoniarelated visits to physician offices.
The use of the pneumonia-specific symptom questionnaire demonstrated that a substantial fraction of pa tients with a low severity of pneumonia continued to re port symptoms beyond 30 days from the time of their diagnosis. This pattern of delayed symptom resolution was mirrored by some, but not all, of the generic health scales provided by the SF-36. Furthermore, the pattern of change, as reflected by the ES for each scale over each fol low up time period, suggests that different scales may measure temporally distinct aspects of recovery in patients with pneumonia. For example, there was substantial im provement in the symptom score over the first 7 days of illness, while several of the physical health scales demonstrated a greater degree of improvement over the remain ing first month of illness.
Published data on the expected rate of resolution of symptoms in patients with pneumonia are limited. In a recent meta analysis of 122 published studies of out comes in patients with pneumonia, only 2 studies included resolution of symptoms as an outcome. S One of these studies considered symptom resolution only until the time of hospital discharge, m while another followed a population of hospitalized adults with incomplete radiographic resolution of their pneumonia and found 63% of survivors were symptom-free at 6 monthsY One other study, by Lehtomaki, included otherwise healthy military recruits in Finland, with a mean age of 21 years. In this study, the mean time to resolution of cough ranged from as short as 4.6 days for patients with mycoplasmal pneumonia (n = 15) to as long as 7.9 days for patients with pneumococcal pneumonia (n 19). ~s This contrasts sharply with our finding that more than 50o/o of patients still reported cough at the day 30 follow up interview. The restriction of the cohort to young, healthy patients and the limitation of follow-up to the time of hospital discharge probably explains the shorter time to cough reso lution in the study by Lehtomaki. Our study relied on a symptom questionnaire that has not been extensively validated, in part because of the absence of an accepted gold stmldard for determining recovery from pneumonia. This is particularly important for the many patients who continue to report symptoms be yond day 30 of their illness. It is possible that for some patients the failure to resolve symptoms beyond day 30 reflects the development of other illnesses rather than the persistent effect of the initial episode of pneumonia. However, patients with higher symptom severity scores at day 30 were more likely to seek physician care for pneumonia related complaints, supporting the conclusion that some of the reported symptoms after day 30 are related to the episode of pneumonia.
The approach of validating the results from the pneumonia symptom score based on its ability to predict pneu monia related physician visits was potentially affected by patient recall bias. The more symptomatic patients may have been more likely to report physician visits and as cribe them to their recent illness. Though the ultimate as signment of visits as pneumonia-related was based on an independent review of patient reported reasons for visits, we have no independent data on the frequency of, and reasons for, visits to physicians during the follow-up time periods.
Some other limitations of this study should be noted. First, the follow-up questionnaires were both self-administered and administered by interview. We have not exam ined the impact of the mode of administration on the re suits of our study and are uncertain about the direction of such a possible effect. Given the potential influence that these two modes of administration could have on questionnaire responses, subsequent studies are required to establish the impact of the mode of administration on measured rates of recovery from pneumonia. Second, as presented in Table 1 , the patients ultimately enrolled in this study were younger, more educated, and probably healthier than the remaining patients in the Pneumonia PORT cohort study who were also considered to be at low risk of short term mortality, but were not enrolled in this study. As a result, we suspect that the resolution of symptoms would be even more delayed among these excluded patients and their symptom burden at 30 and 90 days would be correspondingly greater.
Third, this study relied on an estimation of patients' baseline symptoms and functional status as Judged by their responses to the questionnaires at the time of diagnosis. The bias inherent in this estimation might be in ei- 
